Wordt geladen...
A marker of homologous recombination predicts pathological complete response to neoadjuvant chemotherapy in primary breast cancer
PURPOSE: To assess the prevalence of defective homologous recombination (HR) based DNA repair in sporadic primary breast cancers, examine the clincopathological features that correlate of with defective HR and the relationship with neoadjuvant chemotherapy response. EXPERIMENTAL DESIGN: We examined...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3432445/ https://ncbi.nlm.nih.gov/pubmed/20802015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1027 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|